PresentationMichael UlzEquity Analyst All right. Good morning, everyone, and thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Mike Ulz, one of the biotech analysts here. It's my pleasure to introduce the team from Dyne Therapeutics, including John Cox to my immediate left, President and CEO; as well as Erick Lucera, CFO on the far left. Just before we get started, I need to read a quick disclaimer. For important disclosures, please see the Morgan Stanley Research Disclosure webs ...